Tolcher, A., Flaherty, K., Shapiro, G. I., Berlin, J., Witzig, T., Habermann, T., . . . Cote, G. M. (2018). A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. Oncologist.
シカゴスタイル引用形Tolcher, Anthony, et al. "A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients With Advanced Cancers." Oncologist 2018.
MLA引用形式Tolcher, Anthony, et al. "A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients With Advanced Cancers." Oncologist 2018.
警告: この引用は必ずしも正確ではありません.